Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and Microbiological Characteristics of macrolide-resistant Bordetella pertussis Infection: A case series in Osaka, Japan (2024-2025).

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - 1 Feb 2026

Taniguchi Kimihiro, Yamaguchi Takahiro, Isoda Kenichi, Shiomi Masashi, Kawasaki Yasuhiro, Amo Kiyoko, Wakabayashi Yuki, Kawahara Ryuji, Nozaki Masatoshi

Abstract excerpt

BACKGROUND: Although macrolide antibiotics are an effective first-line treatment for pertussis, the global emergence and spread of macrolide-resistant Bordetella pertussis (MRBP) presents a significant threat to antimicrobial treatment strategies. However, the current status of MRBP in Japan remains unclear due to the lack of a surveillance system. This study aimed to highlight the emergence and clinical impact...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Bordetella pertussis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Macrolides

Share to Microbial Sensitivity Tests

Share to RNA, Ribosomal, 23S

Share to Whooping Cough

Source

Identifiers

PMID: 41611171
DOI: 10.1016/j.jiac.2026.102916

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and Microbiological Characteristics of macrolide-resistant Bordetella pertussis Infection: A case series in Osaka, Japan (2024-2025).PMID 41611171Read ↗

Emergence and spread of MT28 ptxP3 allele macrolide-resistant Bordetella pertussis from 2021 to 2022 in China.Semantic proximity Read ↗

Genomic surveillance reveals global spread of macrolide-resistant Bordetella pertussis linked to vaccine changes.Semantic proximity Read ↗

Whole-genome comparison of two same-genotype macrolide-resistant Bordetella pertussis isolates collected in Japan.Semantic proximity Read ↗

Macrolide Susceptibility and Molecular Characteristics of Bordetella PertussisSemantic proximity Read ↗

Emergence of macrolide-resistant<i>Bordetella pertussis</i>in France, 2024: out of ChinaSemantic proximity Read ↗

Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016–2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides ResistanceSemantic proximity Read ↗

The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.Semantic proximity Read ↗

Genomic Surveillance Reveals Global Spread of Macrolide-Resistant <i>Bordetella pertussis</i> Linked to Vaccine ChangesSemantic proximity Read ↗

Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by<i>ptxP3</i>macrolide-resistant<i>Bordetella pertussis</i>MT28 clone in China: a genomic epidemiology studySemantic proximity Read ↗

Macrolide-Resistant Bordetella pertussis in Hong Kong: Evidence for Post-COVID-19 Emergence of ptxP3-Lineage MT28 Clone from a Hospital-Based Surveillance StudySemantic proximity Read ↗

Macrolide susceptibility and molecular characteristics of Bordetella pertussis.Semantic proximity Read ↗

Sharp rise in high-virulence Bordetella pertussis with macrolides resistance in Northern ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.